Answers are grounded in this paper and cite their sources.
Randomized controlled trial assessed safety and immunogenicity of CS-2034 mRNA vaccine in healthy adults, suggesting potential effectiveness.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: